HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Zhao Selected Research

Carbocyanines

2/2020Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation with Near-Infrared Fluorescence Heptamethine Carbocyanine Dye.
1/2018NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
8/2017Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma.
8/2016Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Zhao Research Topics

Disease

133Neoplasms (Cancer)
12/2022 - 02/2003
29Brain Ischemia (Cerebral Ischemia)
01/2022 - 04/2005
27Inflammation (Inflammations)
01/2022 - 10/2007
23Carcinogenesis
11/2022 - 10/2007
23Reperfusion Injury
01/2022 - 07/2007
22Autoimmune Diseases (Autoimmune Disease)
01/2021 - 06/2003
20Pain (Aches)
01/2022 - 10/2007
20Hypersensitivity (Allergy)
09/2021 - 11/2006
18Infections
12/2021 - 10/2007
17Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 04/2005
16Neoplasm Metastasis (Metastasis)
01/2022 - 01/2014
12Wounds and Injuries (Trauma)
01/2022 - 10/2007
10Hepatocellular Carcinoma (Hepatoma)
03/2022 - 02/2006
10Infarction (Infarctions)
03/2021 - 04/2005
10Ischemia
01/2021 - 01/2010
9Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 08/2009
9Hypoxia (Hypoxemia)
11/2021 - 12/2011
9Hyperglycemia
02/2021 - 08/2006
9Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2010
8Stroke (Strokes)
01/2022 - 04/2005
8Brain Injuries (Brain Injury)
01/2022 - 01/2013
8Virus Diseases (Viral Diseases)
01/2022 - 06/2009
8Body Weight (Weight, Body)
01/2021 - 02/2009
8Breast Neoplasms (Breast Cancer)
11/2020 - 03/2010
7Osteosarcoma (Osteogenic Sarcoma)
04/2022 - 12/2015
7Parkinson Disease (Parkinson's Disease)
04/2022 - 03/2012
7Hypertension (High Blood Pressure)
04/2021 - 10/2007
7Arthritis (Polyarthritis)
01/2021 - 01/2013
7Carcinoma (Carcinomatosis)
01/2021 - 08/2008
7Cardiovascular Diseases (Cardiovascular Disease)
04/2020 - 03/2009
7Stomach Neoplasms (Stomach Cancer)
01/2020 - 11/2007
7Lung Neoplasms (Lung Cancer)
08/2017 - 09/2013
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2022 - 12/2009
6Ischemic Stroke
01/2022 - 06/2013
6Poisoning
01/2022 - 01/2019
6Heart Failure
01/2022 - 04/2008
6Leukemia
01/2019 - 10/2004
6Thrombosis (Thrombus)
01/2018 - 01/2008
6Tuberculosis (Tuberculoses)
09/2015 - 10/2011
6Rheumatoid Arthritis
08/2014 - 12/2006
5COVID-19
06/2022 - 11/2020
5Shock
04/2022 - 12/2013
5Fibrosis (Cirrhosis)
01/2022 - 11/2006
5Melanoma (Melanoma, Malignant)
01/2022 - 06/2014
5Cerebral Infarction
01/2022 - 02/2011
5Hemorrhage
01/2020 - 08/2010
4Genomic Instability
01/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

61Proteins (Proteins, Gene)FDA Link
04/2022 - 11/2006
26Pharmaceutical PreparationsIBA
01/2022 - 02/2009
19Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 08/2009
16Biological ProductsIBA
01/2018 - 08/2008
15Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
14CytokinesIBA
02/2022 - 11/2006
14Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2006
14Small Interfering RNA (siRNA)IBA
01/2022 - 03/2015
14Oxygen (Dioxygen)IBA
01/2022 - 11/2009
13MicroRNAs (MicroRNA)IBA
12/2021 - 05/2011
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2008
10Insulin (Novolin)FDA Link
01/2021 - 08/2006
9Long Noncoding RNAIBA
02/2022 - 01/2018
9AntioxidantsIBA
01/2022 - 10/2007
9AntigensIBA
06/2021 - 06/2003
9Therapeutic UsesIBA
12/2020 - 05/2005
8RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
8InflammasomesIBA
01/2022 - 01/2018
8Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2013
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2021 - 04/2015
7Neuroprotective AgentsIBA
01/2022 - 09/2008
7AntibodiesIBA
01/2022 - 04/2008
7LigandsIBA
01/2022 - 01/2007
7Sirolimus (Rapamycin)FDA Link
12/2020 - 12/2011
6Caspase 3 (Caspase-3)IBA
04/2022 - 10/2010
6ErbB Receptors (EGF Receptor)IBA
03/2020 - 02/2003
6Coloring Agents (Dyes)IBA
02/2020 - 12/2013
6Matrix Metalloproteinases (MMPs)IBA
01/2020 - 09/2002
6Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2018 - 12/2011
6Messenger RNA (mRNA)IBA
01/2018 - 03/2010
5telomerase RNA (bTR)IBA
12/2022 - 01/2016
5Streptozocin (Streptozotocin)FDA Link
06/2022 - 08/2006
5QingkailingIBA
08/2021 - 05/2005
5Interleukin-2 (IL2)IBA
01/2021 - 10/2007
5C-Reactive ProteinIBA
01/2021 - 01/2015
5Monoclonal AntibodiesIBA
12/2020 - 10/2011
5CarcinogensIBA
03/2020 - 05/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 05/2014
5CurcuminIBA
02/2018 - 09/2008
5Peptides (Polypeptides)IBA
01/2017 - 08/2009
4GemcitabineFDA Link
09/2022 - 06/2017
4SeleniumIBA
06/2022 - 01/2021
4InterleukinsIBA
03/2021 - 10/2014

Therapy/Procedure

72Therapeutics
12/2022 - 10/2004
16Transplantation
01/2019 - 08/2005
14Drug Therapy (Chemotherapy)
12/2022 - 12/2006
10Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2021 - 11/2007
6Injections
10/2022 - 12/2014
5Lasers (Laser)
10/2022 - 03/2012
5Immunotherapy
03/2022 - 01/2006
5Operative Time
11/2021 - 10/2012
5Radiotherapy
12/2016 - 04/2010
4Oral Administration
04/2022 - 01/2012